DaVita Reports Q1 Revenues of $3.42B, EPS $2.87 and Raises Profit Outlook
For the quarter ended March 31, 2026, DaVita reported consolidated revenues of $3.416 billion, operating income of $482 million and diluted EPS of $2.87, with operating cash flow of $321 million and free cash flow of $140 million. The company repurchased 3.0 million shares at $133.70 and raised its annual adjusted profit outlook citing strong dialysis demand.
1. Q1 Financial Results
For the quarter ended March 31, 2026, consolidated revenues were $3.416 billion, operating income was $482 million (14.1% margin) and diluted EPS from continuing operations was $2.87, compared with $2.94 in the prior quarter and $2.00 a year ago.
2. Cash Flow and Share Repurchases
Operating cash flow totaled $321 million and free cash flow reached $140 million. The company repurchased 3.0 million shares for $403 million at an average price of $133.70 per share through March 31 and acquired an additional 2.0 million shares for $302 million at $149.81 per share through May 5.
3. Dialysis Volume and Integrated Care Metrics
Total U.S. dialysis treatments were 7,029,525 (91,650 per day), up 0.05% sequentially and 0.1% year-over-year on a normalized non-acquired basis. Integrated kidney care arrangements served approximately 62,600 patients, representing $5.4 billion in annualized medical spend.
4. Profit Outlook
The company raised its annual adjusted profit forecast, citing sustained demand for dialysis services and annual rate increases, including the Medicare base rate adjustment.